ArticlePharmaceutics2023

CD163 Monoclonal Antibody Modified Polymer Prodrug Nanoparticles for Targeting Tumor-Associated Macrophages (TAMs) to Enhance Anti-Tumor Effects.

Zun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.